Portabel Health: Crowned Winner of Flemingsberg Science STARTUP Award 2025

Quickly finding the right personnel is one of the healthcare sector’s major challenges, especially in times of staff shortages and increasing demands for efficiency. Portabel Health offers a modern solution to these problems through a digital platform that makes it easy for care providers to access qualified nurses and healthcare professionals.

Unlike traditional staffing agencies, Portabel Health enables flexible and cost-effective staffing, where the right competence can be matched with the right assignment on short notice. The platform manages the entire process—from matching and scheduling to communication, resulting in reduced administrative burden.

“Winning the Flemingsberg Science Award STARTUP 2025 is proof that we’re on the right path and that our work is being recognized. It gives us even more motivation to continue building a solution the healthcare system truly needs.” — Omar Ahmed, COO and Co-Founder

By combining technology with a deep understanding of healthcare needs, Portabel Health helps ensure high quality of care—even during sudden changes in staffing. The result is a more sustainable staffing solution that strengthens both the work environment and patient care.

“This win opens doors for us to grow faster and continue developing in an environment that fosters innovation. It’s a significant step in our journey and in our mission to create societal value.” — Abdullah Hariss Qurashi, CEO and Founder of Portabel Health

Portabel Health’s innovative work has not gone unnoticed. This year, they are the winners of the Flemingsberg Science STARTUP Award. In addition to the prize of 10,000 SEK, they gain access to coworking spaces in Novum Labs—a creative, knowledge-driven hub for the next generation of tech and healthcare companies, located in the heart of Flemingsberg.

Published On: 23 May 2025
  • Martin Jönsson: “The time is ripe for a breakthrough in dementia treatment”

    Nearly 100,000 people in Sweden suffer from Alzheimer’s. Globally, about 30 million people are thought to have the disease. There is still no cure, but research is approaching a point where new drugs may become crucial. AlzeCure is one of the pharmaceutical companies that has made the most progress.

  • AlzeCure Pharma

    The stimulating environment with access to leading research in the area, and the positive climate on Campus Flemingsberg encourages exciting co-operation

  • Bactigard

    When we needed more space to establish an integrated facility for all our activities, including production, Flemingsberg was the natural choice

  • Biomedrex Genetics

    Thanks to great contacts, including Flemingsberg Science, we quickly got a place at Ana Futura in Flemingsberg.

  • Cellaviva: improving lives through stem cell technology

    Flemingsberg is a cluster for cell therapies that gives us proximity to partners, the clinical research and the trial clinic at Karolinska Hospital where many of the patients have received their treatment.